Trial site
Centro Integral Oncologico Clara Campal
- 6running trials
- 11closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer8 trials
- Lung cancer6 trials
- Head and neck cancer5 trials
- Bladder cancer3 trials
- Gastric and oesophageal cancer3 trials
- Melanoma3 trials
- Ovarian cancer3 trials
- Triple-negative breast cancer3 trials
- Metastatic breast cancer2 trials
- Prostate cancer2 trials
- Chronic myeloid leukaemia1 trial
- Liver and biliary tract cancer1 trial
- and 4 more
- Phase
- Phase 1/27 trials
- Phase 14 trials
- Phase 23 trials
- Phase 32 trials
- Early phase 11 trial
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Terminated3 trials
- Recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- BioNTech SE2 trials
- Menarini Group2 trials
- Bayer1 trial
- BicycleTx Limited1 trial
- Blue Earth Therapeutics Ltd1 trial
- and 10 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
Closed trials
Terminated
Completed
Withdrawn
Terminated
Completed
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Terminated
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
Completed
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
Completed
Completed
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026